Fierce Healthcare

Biden administration launches pilot to mitigate pediatric cancer drug shortages

As President Joe Biden is taking final steps to push one of his signature domestic priorities to accelerate the fight against cancer. A new initiative, announced Monday, aims to mitigate pediatric ...
Medscape

Challenges in Pediatric Pharmacotherapy: Minimizing Medication Errors

Although the 5 "rights" of medication administration (right patient, right drug, right dose, right route, and right frequency) are the basis of most education on drug administration and form the core ...
Yahoo Finance

U.S. Food and Drug Administration Approves Immix Biopharma Rare Pediatric Disease Designation for IMX-110 as a Treatment for Life-Threatening Pediatric Cancer in Children

Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at the time of marketing approval of IMX-110. PRV holders can ...
Business Wire

Papillon Therapeutics Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for PPL-002 for the Treatment of Danon Disease

SAN DIEGO--(BUSINESS WIRE)--Papillon Therapeutics Inc., a clinical-stage biotechnology company advancing a pipeline of multi-systemic genetic medicines directed at the underlying causes of inherited ...
Stocktwits on MSN

LTRN stock gains 18% pre-market: FDA greenlights first pediatric cancer trial for AI-driven drug

Shares of Lantern Pharma Inc. (LTRN) surged nearly 18% in pre-market trading on Friday after the biotech firm said that the U ...